CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients

NCT04195945 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Myeloid Neoplasm

Interventions

DRUG: Liposome-encapsulated Daunorubicin-Cytarabine
DRUG: Cladribine
DRUG: Cytarabine
BIOLOGICAL: Recombinant Granulocyte Colony-Stimulating Factor
DRUG: Mitoxantrone
OTHER: Questionnaire Administration
OTHER: Quality-of-Life Assessment

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]